Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy

Some Postmenopausal Women From Breast Cancer Can Protect Hormonal Therapy.


In a discovery that seems to table the dominant clear-headedness that any form of hormone replacement analysis raises the risk of breast cancer, a unfamiliar look at some old data suggests that estrogen-only hormone psychoanalysis might protect a under age subset of postmenopausal women against the disease. "Exogenous estrogen such as hormone psychotherapy is actually protective" in women who have a wretched risk for developing bust tumors, said study author Dr Joseph Ragaz, a medical oncologist and clinical professor in the School of Population & Public Health at the University of British Columbia in Vancouver Naturomax Pills. With his colleagues, Ragaz took another expression at matter from the Women's Health Initiative (WHI) study, a country-wide burr under the saddle that has focused on ways to check soul and colorectal cancer, as well as core affliction and fracture risk, in postmenopausal women.



The pair planned to present its findings Thursday at the San Antonio Breast Cancer Symposium in Texas. Research presented at medical meetings is not analyzed by home experts, unequal studies that appear in peer-reviewed medical journals, and all such findings should be considered preliminary buy Phentemine without a prescription. Launched in 1991, the WHI includes more than 161000 US women between the ages of 50 and 79.



Two groups were vicinity of the examination - women who had had hysterectomies and took estrogen unequalled as hormone replacement group therapy and a assembly that took estrogen with the addition of progestin hormone replacement therapy. The coalition cure headache was halted in 2002 after it became wholly those women were at increased chance for heart disease and breast cancer.



In the rejuvenated look at the estrogen-only group, Ragaz said, "we looked at women who did not have high-risk features". They found that women with no former depiction of soft-hearted breast disease had a 43 percent reduction teat cancer risk on estrogen; women with no parentage history with a first-degree relevant with breast cancer had a 32 percent peril reduction and women without previous hormone use had a 32 percent reduced risk.